Experienced in Jaundice

Dr. Obaid Shaikh

Hepatology
Dubois Regional Medical Center
100 Hospital Ave, 
Du Bois, PA 
 (551.4 mi)
Offers Telehealth
46 Years of Experience
Experienced in Jaundice
Dubois Regional Medical Center
100 Hospital Ave, 
Du Bois, PA 
 (551.4 mi)
OverviewInsuranceLocationsClinical Research

Overview

Obaid Shaikh is a Hepatologist in Du Bois, Pennsylvania. Dr. Shaikh has been practicing medicine for over 46 years and is rated as an Experienced provider by MediFind in the treatment of Jaundice. His top areas of expertise are Hepatitis, Hepatitis C, Visceromegaly, Cirrhosis, and Liver Transplant.

His clinical research consists of co-authoring 52 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Year
1979
Specialties
Hepatology
Licenses
Specialist in PA
Hospital Affiliations
Magee Womens Hospital Of Upmc Health System
Upmc Presbyterian Shadyside
Penn Highlands Dubois
Upmc Passavant
Languages Spoken
English
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Locations

DUBOIS REGIONAL MEDICAL CENTER
100 Hospital Ave, Du Bois, PA 15801
Other Locations
DUBOIS REGIONAL MEDICAL CENTER
621 S Main St, Penn Highlands Gastroenterology, Du Bois, PA 15801
UNIVERSITY OF PITTSBURGH PHYSICIANS
300 Halket St, Pittsburgh, PA 15213

Additional Areas of Focus

Dr. Shaikh has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
Enrollment Status: Completed
Publish Date: January 14, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
Phase 3 Prospective, Randomized, Blinded, and Controlled Investigation of HepaSphere/QuadraSphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Carcinoma
Phase 3 Prospective, Randomized, Blinded, and Controlled Investigation of HepaSphere/QuadraSphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Carcinoma
Enrollment Status: Terminated
Publish Date: November 30, 2021
Intervention Type: Procedure, Device
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
Enrollment Status: Terminated
Publish Date: April 26, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 3 Less Clinical Trials

52 Total Publications

Hepatitis Delta Coinfection Rates and All-Cause Mortality Among Hepatitis B-Infected Veterans in the USA.
Hepatitis Delta Coinfection Rates and All-Cause Mortality Among Hepatitis B-Infected Veterans in the USA.
Journal: Journal of viral hepatitis
Published: August 15, 2024
Similar Doctors
Experienced in Jaundice
Dr. Mitchell Conn
Hepatology
Experienced in Jaundice
Dr. Mitchell Conn
Hepatology

Mount Nittany Medical Center Health Services Inc

3901 S Atherton St, 2 Mount Nittany Physician Group, 
State College, PA 
 (55.8 mi)
814-278-4631
Languages Spoken:
English
See accepted insurances

Mitchell Conn is a Hepatologist in State College, Pennsylvania. Dr. Conn and is rated as an Advanced provider by MediFind in the treatment of Jaundice. His top areas of expertise are Trichohepatoenteric Syndrome, Portal Hypertension, Hepatitis, Endoscopy, and Colonoscopy.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile